Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Identify scenarios where active funds may outperform, focusing on market environments, fees, and your risk tolerance.
14,457 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
As investors prepare for Personalis (PSNL) 2025 earnings, this guide breaks down what to watch, how to interpret the ...
A social media creator was arrested after a snowball fight with NYC officers in Washington Square Park. The event hig...
A press package from the south korea national service’s agency exposed seed phrases for seized wallets, briefly drain...
U.S.-Israel strikes on Iran trigger sharp market moves as Trump calls regime change, raising the stakes for investors...
A new round of Iranian strikes tests the region’s missile defenses and buoyed defense stocks, while households weigh ...
Gen Z is delaying homeownership as debt burdens grow and mortgage rates stay high. A new snapshot shows tiny shares o...
When a member of the texas capital bancshares board makes a sizable purchase, it often prompts questions from investo...
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A fresh AI-related order sparked a sharp move in Aehr Test Systems stock, with investors pricing in potential growth ...
Two U.S. startups, Archer Aviation and Joby Aviation, are racing to pioneer urban air mobility. This guide breaks dow...
Investors often wonder if Nvidia stock should be bought before major AI events. This article breaks down historical p...